A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies
|
|||||
       
  |
 Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, equity, Europe, genomics, investment, licensing, life sciences, pharmaceuticals 
A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray Comments are closed Intellectual property, New products biomedical, chemistry, engineering, licensing, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, U.K. 
Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders. . . . → Read More: Biotechs Partner on Agitation Detection Technology One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, life sciences, mathematics, medical device, patent, physical sciences, psychiatric, software 
A new company spun off from Harvard University aims to simplify data analysis, management, and collaboration for life science researchers. . . . → Read More: New Company Forms to Ease Scientific Data Operations Comments are closed Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, licensing, life sciences, mathematics, software, university 
A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases. . . . → Read More: Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, Europe, genomics, licensing, life sciences, nanotechnology, pharmaceuticals, university 
A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells. . . . → Read More: Pharma, Biotech Partner on Off-the-Shelf Cell Therapies Comments are closed Intellectual property, Joint ventures/collaborations, New products Asia, biomedical, biotechnology, entrepreneurs, genomics, Israel, Japan, licensing, life sciences, pharmaceuticals, stem cells
GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders. . . . → Read More: GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, genomics, licensing, pharmaceuticals, U.K. 
A therapy designed to regenerate healthy gut microbes for treating dangerous intestinal infections is licensed for commercialization to Nestlé Health Science. . . . → Read More: Microbiome Drug Candidate Licensed in $525M Deal Comments are closed Intellectual property, New products biomedical, biotechnology, clinical trials, Europe, licensing, life sciences, pharmaceuticals 
A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients. . . . → Read More: Patent Awarded for Safer Cancer Drug Delivery Comments are closed Intellectual property, New products biomedical, cancer, chemistry, life sciences, manufacturing, nanotechnology, patent, pharmaceuticals, USPTO 
A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million. . . . → Read More: Gene Therapy Company Starts-Up, Gains $200M Comments are closed Intellectual property, New products Asia, biomedical, biotechnology, entrepreneurs, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university, venture capital |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
